Radiation Oncology/Therapy: Page 92

IORT boost yields improved long-term breast tumor control
By Becky McCall
Intraoperative radiotherapy (IORT) administered as a boost during breast surgery provides outstanding tumor control outcomes compared to a conventional boost, attendees were told at the European Society for Therapeutic Radiology and Oncology meeting earlier this month in London.
May 22, 2011
RTOG announces glioblastoma trial results
By Cynthia E. Keen
A trial comparing two chemotherapy doses combined with radiotherapy showed equivocal results for glioblastoma. However, it did prove the feasibility of collecting and analyzing tumor tissue prospectively in an international, multicenter setting, the Radiation Therapy Oncology Group (RTOG) announced.
May 19, 2011
Oraya completes clinical trial enrollment
By AuntMinnieEurope.com staff writers
Oraya Therapeutics has completed enrollment of its INTREPID (IRay plus anti-VEGF Treatment for Patients with Wet Age-related Macular Degeneration) clinical trial in Europe.
May 18, 2011
PET enables better monitoring of intratumoral changes
By Becky McCall
Growing use of hypofractionation in clinical practice and its link to increased treatment resistance due to tumor cell hypoxia means that it may be beneficial to visualize and quantify hypoxic areas with PET imaging to monitor changes in tumor metabolism during treatment.
May 18, 2011
2011 05 19 11 21 20 441 Bussink Thumb
ViewRay nets U.S., European patents
By AuntMinnieEurope.com staff writers
Image-guided therapy developer ViewRay has been awarded patents in the U.S. and Europe for its combined MRI and radiation therapy technologies.
May 18, 2011
IsoRay nets revenue gain in Q3
By AuntMinnieEurope.com staff writers
A 21% increase in patient cases helped medical isotope developer IsoRay Medical to a third-quarter revenue gain and a lower net loss compared to the same quarter of the prior year.
May 16, 2011
IBA revenues increase by 20% in Q1
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) reported nearly 20% revenue growth in its first quarter.
May 11, 2011
PET/CT helps target radiation therapy of NSCLC tumors
By Becky McCall
LONDON - PET/CT prior to radiotherapy can help oncologists target a more powerful dose of radiation to non-small cell lung cancer (NSCLC), whilst keeping dose low in other areas of the organ, according to research presented at this week's European Society for Therapeutic Radiology and Oncology meeting.
May 10, 2011
2011 05 11 14 00 56 747 Estro Clinical 394
Nucletron to show gyn, prostate devices at ESTRO
By AuntMinnieEurope.com staff writers
Radiation oncology firm Nucletron plans to highlight new radiotherapy offerings at the upcoming European Society for Therapeutic Radiology and Oncology (ESTRO) annual meeting in London, the company said.
May 4, 2011
Elekta to feature RFID system at ESTRO
By AuntMinnieEurope.com staff writers
Oncology firm Elekta plans to feature a work-in-progress radiofrequency identification (RFID) system at the upcoming European Society for Therapeutic Radiology and Oncology (ESTRO) in London, the company said.
May 4, 2011
Calypso wins Italian install
By AuntMinnieEurope.com staff writers
Electromagnetic localization technology developer Calypso Medical Technologies has installed its first tumor-tracking package in Italy, the company said.
May 4, 2011
Eckert & Ziegler grows Q1 revenues
By AuntMinnieEurope.com staff writers
Earnings from its isotope products segment powered Eckert & Ziegler, parent company of radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products, to a prosperous first quarter.
May 2, 2011
Previous Page
Page 92 of 126
Next Page